The quest to combat Alzheimer’s disease has taken a promising turn with research highlighting the potential of calcium alpha-ketoglutarate (caakg). This compound, initially investigated for its health-promoting properties in aging, is now showing remarkable benefits in restoring synaptic function – a critical element frequently enough disrupted in the early stages of Alzheimer’s. You might be wondering how this could impact the future of treatment.
